BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18375821)

  • 1. Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma.
    Miselis NR; Wu ZJ; Van Rooijen N; Kane AB
    Mol Cancer Ther; 2008 Apr; 7(4):788-99. PubMed ID: 18375821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumors.
    Krug S; Abbassi R; Griesmann H; Sipos B; Wiese D; Rexin P; Blank A; Perren A; Haybaeck J; Hüttelmaier S; Rinke A; Gress TM; Michl P
    Int J Cancer; 2018 Oct; 143(7):1806-1816. PubMed ID: 29696624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of liposome clodronate on renal leukocyte populations and renal fibrosis in murine obstructive nephropathy.
    Kitamoto K; Machida Y; Uchida J; Izumi Y; Shiota M; Nakao T; Iwao H; Yukimura T; Nakatani T; Miura K
    J Pharmacol Sci; 2009 Nov; 111(3):285-92. PubMed ID: 19893275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suramin inhibits the growth of malignant mesothelioma in vitro, and in vivo, in murine flank and intraperitoneal models.
    Cook JW; Sterman DH; Singhal S; Smythe WR; Kaiser LR
    Lung Cancer; 2003 Dec; 42(3):263-74. PubMed ID: 14644513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encapsulation in a rapid-release liposomal formulation enhances the anti-tumor efficacy of pemetrexed in a murine solid mesothelioma-xenograft model.
    Eldin NE; Abu Lila AS; Kawazoe K; Elnahas HM; Mahdy MA; Ishida T
    Eur J Pharm Sci; 2016 Jan; 81():60-6. PubMed ID: 26415830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated progression of asbestos-induced mesotheliomas in heterozygous p53+/- mice.
    Vaslet CA; Messier NJ; Kane AB
    Toxicol Sci; 2002 Aug; 68(2):331-8. PubMed ID: 12151629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clodronate-Liposome Mediated Macrophage Depletion Abrogates Multiple Myeloma Tumor Establishment In Vivo.
    Opperman KS; Vandyke K; Clark KC; Coulter EA; Hewett DR; Mrozik KM; Schwarz N; Evdokiou A; Croucher PI; Psaltis PJ; Noll JE; Zannettino AC
    Neoplasia; 2019 Aug; 21(8):777-787. PubMed ID: 31247457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy.
    Hoda MA; Mohamed A; Ghanim B; Filipits M; Hegedus B; Tamura M; Berta J; Kubista B; Dome B; Grusch M; Setinek U; Micksche M; Klepetko W; Berger W
    J Thorac Oncol; 2011 May; 6(5):852-63. PubMed ID: 21358348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination.
    Yamaguchi T; Fushida S; Yamamoto Y; Tsukada T; Kinoshita J; Oyama K; Miyashita T; Tajima H; Ninomiya I; Munesue S; Harashima A; Harada S; Yamamoto H; Ohta T
    Gastric Cancer; 2016 Oct; 19(4):1052-1065. PubMed ID: 26621525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rejection of intradermally injected syngeneic tumor cells from mice by specific elimination of tumor-associated macrophages with liposome-encapsulated dichloromethylene diphosphonate, followed by induction of CD11b(+)/CCR3(-)/Gr-1(-) cells cytotoxic against the tumor cells.
    Takahashi T; Ibata M; Yu Z; Shikama Y; Endo Y; Miyauchi Y; Nakamura M; Tashiro-Yamaji J; Miura-Takeda S; Shimizu T; Okada M; Ueda K; Kubota T; Yoshida R
    Cancer Immunol Immunother; 2009 Dec; 58(12):2011-23. PubMed ID: 19365632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L; Han S; Jiao Y; Jiang S; He X; Li P
    Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach.
    Zeisberger SM; Odermatt B; Marty C; Zehnder-Fjällman AH; Ballmer-Hofer K; Schwendener RA
    Br J Cancer; 2006 Aug; 95(3):272-81. PubMed ID: 16832418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts.
    De Cesare M; Sfondrini L; Pennati M; De Marco C; Motta V; Tagliabue E; Deraco M; Balsari A; Zaffaroni N
    J Transl Med; 2016 Jan; 14():25. PubMed ID: 26810896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo transfer of bacterial marker genes results in differing levels of gene expression and tumor progression in immunocompetent and immunodeficient mice.
    Lukacs KV; Porter CD; Pardo OE; Oakley RE; Steel RM; Judd DV; Browning JE; Geddes DM; Alton EW
    Hum Gene Ther; 1999 Sep; 10(14):2373-9. PubMed ID: 10515457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8.
    Fang W; Ye L; Shen L; Cai J; Huang F; Wei Q; Fei X; Chen X; Guan H; Wang W; Li X; Ning G
    Carcinogenesis; 2014 Aug; 35(8):1780-7. PubMed ID: 24608042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouse.
    Kim SW; Kim JS; Papadopoulos J; Choi HJ; He J; Maya M; Langley RR; Fan D; Fidler IJ; Kim SJ
    Int Immunopharmacol; 2011 Jul; 11(7):862-72. PubMed ID: 21251905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
    Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF
    Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.
    Lenzi R; Rosenblum M; Verschraegen C; Kudelka AP; Kavanagh JJ; Hicks ME; Lang EA; Nash MA; Levy LB; Garcia ME; Platsoucas CD; Abbruzzese JL; Freedman RS
    Clin Cancer Res; 2002 Dec; 8(12):3686-95. PubMed ID: 12473577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
    Nici L; Monfils B; Calabresi P
    Clin Cancer Res; 2004 Nov; 10(22):7655-61. PubMed ID: 15569998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages Promote Growth of Squamous Cancer Independent of T cells.
    Wu FL; Nolan K; Strait AA; Bian L; Nguyen KA; Wang JH; Jimeno A; Zhou HM; Young CD; Wang XJ
    J Dent Res; 2019 Jul; 98(8):896-903. PubMed ID: 31189369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.